Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: A 30‐month pilot study
Christopher B. O'brien, John R. Senior, Renu Arora‐Mirchandani, Ashok K. Batta, Gerald Salen – 1 November 1991 – We investigated the effects of once‐daily oral administration of 10 mg/kg ursodeoxycholic acid (generic name, ursodiol) on elevated serum enzyme activities, bilirubin, cholesterol, bile acids and symptoms in patients with primary sclerosing cholangitis.